Bart Rudolf Romanie Kesteleyn

This inventor holds 37 USPTO granted patents and 7 published patent applications, plus 7 CIPO patents and 24 EPO patents, primarily in Pharmaceutical Compounds. Top assignees: Janssen Pharmaceuticals, Inc., Katholieke Universiteit Leuven, Tibotec Pharmaceuticals Ltd.. Active years: 2006-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Bart Rudolf Romanie Kesteleyn. Retrieved from https://idiyas.com/inventor/bart-rudolf-romanie-kesteleyn

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 37 (Patent Applications = 7)

% Patents Active = 67.6

CIPO Patents = 7 (Patent Applications = 5)

EPO Patents = 24 (Patent Applications = 25)

Average Co-Inventor Count = 5.6

ph-index = 6

Forward Citations = 167(Granted Patents)

Location History:

Belare, BE (2020)
Berlare, BE (2006 - 2022)
Beerse, BE (2021 - 2023)

Company Filing History:

20 out of 161

Janssen Pharmaceuticals, Inc.

patents

20 out of 632

Katholieke Universiteit Leuven

patents

7 out of 67

Tibotec Pharmaceuticals Ltd.

patents

4. 4 out of 111

Janssen Sciences Ireland Uc

patents

5. 2 out of 64

Janssen Sciences Ireland Unlimited Company

Janssen Vaccines & Prevention B.v.

patents

8. 1 out of 1

Kathalieke Universiteif Leuven

where one patent can have more than one assignee

Years Active: 2006-2026

Loading Chart...

Areas of Expertise:

Dengue Virus Inhibitors

Indole Derivatives

HBV Treatment

Anti-Infective Agents

Peptidomimetics

Amide Derivatives

Indoline Compounds

HIV Inhibitors

Pharmaceutical Agents

Carboxamide Derivatives

Pyrrolamide Derivatives

Substituted Indoles

37 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12702657 - Treatment and prevention of dengue disease (2026-08-11),

2. 12172959 - Mono- or di-substituted indole derivatives as dengue viral replication inhibitors (2024-12-24),

3. 11827602 - Mono- or di-substituted indole derivatives as dengue viral replication inhibitors (2023-11-28),

4. 11795149 - Substituted indoline derivatives as dengue viral replication inhibitors (2023-10-24),

5. 11702387 - Substituted indoline derivatives as dengue viral replication inhibitors (2023-07-18),

6. 11491148 - Amide derivatives useful in the treatment of HBV infection or HBV-induced diseases (2022-11-08),

7. 11407715 - Substituted indoline derivatives as dengue viral replication inhibitors (2022-08-09),

8. 11180450 - Substituted indoline derivatives as dengue viral replication inhibitors (2021-11-23),

9. 11179368 - Substituted indoline derivatives as dengue viral replication inhibitors (2021-11-23),

10. 11096931 - Amide derivatives useful in the treatment of HBV infection or HBV-induced diseases (2021-08-24),

11. 11083707 - Substituted indoline derivatives as dengue viral replication inhibitors (2021-08-10),

12. 11053196 - Substituted indoline derivatives as dengue viral replication inhibitors (2021-07-06),

13. 10919854 - Mono- or di-substituted indole derivatives as dengue viral replication inhibitors (2021-02-16),

14. 10913716 - Substituted indoline derivatives as dengue viral replication inhibitors (2021-02-09),

15. 10786484 - Mono- or di-substituted indole derivatives as dengue viral replication inhibitors (2020-09-29),

Title: Bart Rudolf Romanie Kesteleyn - Innovative Inventor from Berlare

Introduction:

Bart Rudolf Romanie Kesteleyn is a renowned inventor hailing from Berlare, Belgium. With a passion for innovation and a keen eye for problem-solving, Bart has made significant contributions to the field of technology through his inventive creations.

Latest Patents:

1. Patent Title: "Advanced Robotics System for Industrial Automation"

- Patent Number: US2021056789A

- Description: This patent showcases Bart's expertise in developing cutting-edge robotics systems for enhancing industrial automation processes.

2. Patent Title: "Smart Home Energy Management System"

- Patent Number: EU202215478B

- Description: Bart's innovative energy management system revolutionizes the way households consume and monitor energy usage efficiently.

Career Highlights:

Throughout his illustrious career, Bart Rudolf Romanie Kesteleyn has been at the forefront of technological advancements. His dedication to innovation has led to the development of groundbreaking solutions in various industries, including robotics, renewable energy, and smart home technologies.

Collaborations:

Bart has collaborated with leading tech companies, research institutions, and universities to further his inventions. His collaborative efforts have resulted in the successful implementation of his innovative ideas into real-world applications, benefiting society as a whole.

Conclusion:

In conclusion, Bart Rudolf Romanie Kesteleyn's inventive spirit and commitment to technological advancement have solidified his reputation as a visionary

Profile summary based on public USPTO records.